liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Tissue IGF-I Measured by Microdialysis Reflects Body Glucose Utilization After rhIGF-I Injection in Type 1 Diabetes
Karolinska Hospital and Institute, Sweden.
Karolinska Hospital and Institute, Sweden; University of Helsinki, Finland.
Karolinska Hospital and Institute, Sweden.
Karolinska Hospital and Institute, Sweden.
Show others and affiliations
2015 (English)In: Journal of Clinical Endocrinology and Metabolism, ISSN 0021-972X, E-ISSN 1945-7197, Vol. 100, no 11, 4299-4306 p.Article in journal (Refereed) PublishedText
Abstract [en]

Context: Type 1 diabetes is associated with portal insulin deficiency and disturbances in the GH-IGF axis including low circulating IGF-I and GH hypersecretion. Whether peripheral hyperinsulinemia and GH hypersecretion, which are relevant to the development of vascular complications, result in elevated tissue IGF-I remains unknown. Objective: The purpose of this study was to determine the relationship between whole-body glucose uptake and tissue IGF-I measured by microdialysis. Design: This was a single-blind placebo-controlled crossover study. Setting: The setting was a tertiary pediatric endocrine referral center. Participants: The participants were seven young male adults with type 1 diabetes. Intervention: After an overnight fast, a 6-h lasting euglycemic clamp was performed (constant insulin infusion at 0.5mU/kg x minute and variable glucose infusion rate [GIR]) and a subcutaneous injection of recombinant human (rh) IGF-I (120 mu g/kg) or saline was given after 2 hours. In parallel, tissue IGF-I levels were determined by microdialysis (md-IGF-I). Main Outcome Measures: md-IGF-I levels in muscle and subcutaneous fat, and GIR were determined. Results: md-IGF-I levels were detectable but unchanged after saline. After rhIGF-I, muscle and subcutaneous fat md-IGF-I increased during the second and third hour and then reached a plateau up to 10-fold higher than baseline (P less than .001). GIR was unchanged after saline, whereas it increased 2.5-fold concomitantly with the increase in md-IGF-I (P less than .0001). In contrast, serum IGF-I was increased already at 30 minutes after rhIGF-I and reached a plateau 2-fold above baseline (P less than .0001). Conclusion: We demonstrate that md-IGF-I measurements are valid and physiologically relevant by reflecting rhIGF-I-induced glucose uptake. Future studies should be conducted to elucidate the role of local tissue IGF-I in diabetic vascular complications.

Place, publisher, year, edition, pages
ENDOCRINE SOC , 2015. Vol. 100, no 11, 4299-4306 p.
National Category
Clinical Medicine
URN: urn:nbn:se:liu:diva-123528DOI: 10.1210/jc.2015-2070ISI: 000364925700062PubMedID: 26331550OAI: diva2:886251

Funding Agencies|Jalmari and Rauha Ahokas Foundation; Samariten Foundation; Swedish Child Diabetes Foundation (Barndiabetesfonden); Foundation Frimurare Barnhuset in Stockholm; Society for Child Care (Sallskapet Barnavard); HRH Crown Princess Lovisa Society for Medicine; Stockholm County Council; ISPAD; Biomedicum Helsinki Foundation; Finnish Foundation for Pediatric Research; NovoNordisk (Bagsvaerd, Denmark); Ipsen (Kista, Sweden)

Available from: 2015-12-22 Created: 2015-12-21 Last updated: 2015-12-22

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Bang, Peter
By organisation
Division of Clinical SciencesFaculty of Medicine and Health Sciences
In the same journal
Journal of Clinical Endocrinology and Metabolism
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 52 hits
ReferencesLink to record
Permanent link

Direct link